Link China Pharma Solutions

Beating Recession Blues and Fighting TB Infection: Sino-UK Companies' TB Vaccine Partnership Deal

UK Cambridge based vaccine company ImmBio joined-up with Sinopharm Vaccine Institute to co-develop its T-BioVax Vaccine against TB Infection. ImmunoBiology Ltd, a vaccine R&D company based Babraham Research Campus near Cambridge UK recently signed initial cooperation agreement with LIBP a subsidiary company under Sinopharm’s biological products division – CNBG (China National Biotech Group) with close coordination by Cambridge based biopharma consultancy company – Link China Pharma Solutions. - October 15, 2011